Susquehanna Growth Equity Makes Majority Growth Investment in MediSpend

May 26, 2021

Susquehanna Growth Equity (SGE) made a majority growth investment in MediSpend, a Portsmouth, New Hampshire–based provider of SaaS compliance solutions for the life sciences industry. The investment will fund product and client expansion across life sciences; Scott Feldman of SGE will join MediSpend’s board alongside CEO Craig Hauben and existing investors Steve Eaton and Dave Cormack. Financial terms were not disclosed.

Buyers
Susquehanna Growth Equity
Targets
MediSpend
Industry
Cloud & SaaS
Location
New Hampshire, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.